Effects and safety profile of betahistine in patients in the Russian contingent of OSVaLD, an open-label observational study in vestibular vertigo

Autor: Morozova SV, Alekseeva NS, Lilenko SV, Matsnev EI, Melnikov OA

Publikováno v: International Journal of General Medicine, Vol 2015, Iss default, Pp 47-53 (2015)

Svetlana Vyacheslavovna Morozova,1 Natalia Stepanovna Alekseeva,2 Sergey Vasilyevich Lilenko,3 Eduard Ivanovich Matsnev,4 Oleg Anatol'evich Melnikov51Department of Ear, Nose, and Throat, State Budgetary Educational Institution of Higher Professional

Externí odkaz: https://doaj.org/article/b5cd50d292454c14ac074e1490fbc617

[Application of new technologies in postgraduate education of otorhinolaryngologists].

Autor: Svistushkin VM; Sechenov First Moscow State Medical University, Moscow, Russia., Morozova SV; Sechenov First Moscow State Medical University, Moscow, Russia., Shadyev TK; Sechenov First Moscow State Medical University, Moscow, Russia., Sinkov EV; Sechenov First Moscow State Medical University, Moscow, Russia.

Publikováno v: Vestnik otorinolaringologii [Vestn Otorinolaringol] 2022; Vol. 87 (4), pp. 118-122.

['School of Excellence' in the structure of teaching otorhinolaryngology at the department of diseases of the ear, nose and throat of Sechenov University: experience and perspective].

Autor: Svistushkin VM; First Moscow State Medical University, Moscow, Russia 119991., Morozova SV; First Moscow State Medical University, Moscow, Russia 119991., Zolotova AV; First Moscow State Medical University, Moscow, Russia 119991.

Publikováno v: Vestnik otorinolaringologii [Vestn Otorinolaringol] 2019; Vol. 84 (5), pp. 89-92.

Effectiveness of betahistine (48 mg/day) in patients with vestibular vertigo during routine practice: The VIRTUOSO study.

Autor: Parfenov VA; Neurology Department, I.M. Sechenov First Moscow State Medical University, Moscow, Russia., Golyk VA; Neurology and Border States Department, Ukrainian State Institute of Medical and Social Problems of Disability, Ministry of Public Health of Ukraine, Dnipropetrovsk, Ukraine., Matsnev EI; State Scientific Centre of the Russian Federation, Institute of Biomedical Problems of Russian Academy of Sciences, Moscow, Russia., Morozova SV; ENT Department, I.M. Sechenov First Moscow State Medical University, Moscow, Russia., Melnikov OA; ANO Guta Clinic, Moscow, Russia., Antonenko LM; Neurology Department, I.M. Sechenov First Moscow State Medical University, Moscow, Russia., Sigaleva EE; State Scientific Centre of the Russian Federation, Institute of Biomedical Problems of Russian Academy of Sciences, Moscow, Russia., Situkho MI; Clinical Audiology and Vestibology Department, O.S. Kolomyichenko Otolaryngology Institute, Kyiv, Ukraine., Asaulenko OI; Kyiv City Clinical Hospital № 9, Neurology Department, Kyiv, Ukraine.; P.L. Shupyk National Medical Academy of Postgraduate Education, Kyiv, Ukraine., Popovych VI; ENT Department, Ivano-Frankivsk Regional Clinical Hospital, Ivano-Frankivsk, Ukraine.; Ivano-Frankivsk National Medical University, Ivano-Frankivsk, Ukraine., Zamergrad MV; ANO Guta Clinic, Moscow, Russia.; Department of Neurology, Russian Medical Academy of Postgraduate Education, Moscow, Russia.

Publikováno v: PloS one [PLoS One] 2017 Mar 30; Vol. 12 (3), pp. e0174114. Date of Electronic Publication: 2017 Mar 30 (Print Publication: 2017).

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.